scholarly article | Q13442814 |
P2093 | author name string | Lai-Hua Xie | |
Hairuo Wen | |||
Judith K Gwathmey | |||
P2860 | cites work | Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats | Q68425427 |
Studies defining minimal receptor domains for angiotensin II | Q69654036 | ||
Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells | Q69946285 | ||
Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells | Q70284451 | ||
Angiotensin II activation of a chloride current in rabbit cardiac myocytes | Q71696394 | ||
Coronary Kinin Generation Mediates Nitric Oxide Release After Angiotensin Receptor Stimulation | Q71867405 | ||
Angiotensin II inhibits protein kinase A-dependent chloride conductance in heart via pertussis toxin-sensitive G proteins | Q71971787 | ||
Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury | Q72028633 | ||
Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor | Q72043231 | ||
Characterization of an angiotensin-II-activated chloride current in rabbit sino-atrial cells | Q72732281 | ||
Cell biology and genetics of angiotensin in cardiovascular disease | Q72817081 | ||
Signal transduction pathways of angiotensin II--induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers | Q72873648 | ||
Central angiotensin IV binding sites: distribution and specificity in guinea pig brain | Q72922615 | ||
Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues | Q73127508 | ||
Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts | Q73606446 | ||
Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries | Q73762643 | ||
Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy | Q73789360 | ||
Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats | Q73807616 | ||
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation | Q73854861 | ||
Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans | Q73889054 | ||
The nuclear deltaB isoform of Ca2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes | Q73919914 | ||
Immunohistochemical study of angiotensin receptors in normal human sweat glands and eccrine poroma | Q74079487 | ||
Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2 | Q77985799 | ||
Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II in vivo | Q78850683 | ||
Targeting mitochondrial oxidative stress in heart failure throttling the afterburner | Q84212640 | ||
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 | ||
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration | Q24290268 | ||
Angiotensin II-induced sudden arrhythmic death and electrical remodeling | Q24302066 | ||
Subclasses of angiotensin II binding sites and their functional significance | Q28336035 | ||
Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor | Q28565959 | ||
Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization | Q28573785 | ||
Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype | Q28581981 | ||
Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane | Q28583095 | ||
Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling | Q28583271 | ||
Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor | Q28585163 | ||
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation | Q29620430 | ||
Recent progress in angiotensin II type 2 receptor research in the cardiovascular system | Q33534457 | ||
Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. | Q33655919 | ||
Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat | Q33689411 | ||
The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? | Q33743695 | ||
Angiotensin receptors: distribution, signalling and function | Q33941829 | ||
Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology | Q34059645 | ||
The angiotensin II AT2 receptor is an AT1 receptor antagonist. | Q34086986 | ||
A novel angiotensin II type 1 receptor-associated protein induces cellular hypertrophy in rat vascular smooth muscle and renal proximal tubular cells | Q34301246 | ||
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone | Q34378188 | ||
The angiotensin II type 1 receptor and receptor-associated proteins | Q34408092 | ||
Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension | Q34415739 | ||
The distribution of angiotensin II type 1 receptors, and the tissue renin-angiotensin systems | Q34450847 | ||
Circulating and tissue angiotensin systems | Q34553006 | ||
Bioactive angiotensin peptides: focus on angiotensin IV. | Q34553630 | ||
Angiotensin II-mediated signal transduction pathways. | Q34555180 | ||
Angiotensin II as a cardiovascular risk factor | Q34610027 | ||
Signal transduction systems and atrial fibrillation | Q34682899 | ||
The intracellular renin-angiotensin system: implications in cardiovascular remodeling | Q34750404 | ||
Current molecular models for NADPH oxidase regulation by Rac GTPase | Q34915029 | ||
The superoxide-generating NADPH oxidase: structural aspects and activation mechanism | Q35003216 | ||
The alpha-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocytes requires calcium influx, protein kinase C, and calmodulin-regulated pathways | Q43512572 | ||
Angiotensin II stimulates cardiac L-type Ca(2+) current by a Ca(2+)- and protein kinase C-dependent mechanism | Q43541609 | ||
Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. | Q43744753 | ||
Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes | Q43906820 | ||
Angiotensin II increases L-type Ca2+ current in gramicidin D-perforated adult rabbit ventricular myocytes: comparison with conventional patch-clamp method | Q43971610 | ||
Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators | Q44128026 | ||
Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure | Q44240398 | ||
Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization | Q44285594 | ||
Purification and identification of endogenous anti-opioid substances from bovine brain | Q44345801 | ||
Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor | Q44413571 | ||
Effects of the Angiotensin II Subtype 1 Receptor Antagonist Losartan on Functional Recovery of Isolated Rat Hearts Undergoing Global Myocardial Ischemia‐Reperfusion | Q44657166 | ||
Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice | Q44838733 | ||
Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide | Q45256332 | ||
G alpha 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. | Q45295556 | ||
Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT1 receptor blockade in human atrial myocardium | Q46257254 | ||
Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution | Q46802781 | ||
Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT1 receptor in guinea pig atrial myocytes | Q46988602 | ||
Structural analysis and regulation of angiotensin II receptors | Q47874551 | ||
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system | Q47987915 | ||
Cloning and expression of a novel angiotensin II receptor subtype | Q48173445 | ||
Effects of the renin-angiotensin system on the current I(to) in epicardial and endocardial ventricular myocytes from the canine heart. | Q48890673 | ||
Angiotensin II receptors in normal and failing human hearts. | Q52245852 | ||
Oxygen free radicals in essential hypertension | Q54413227 | ||
Myocardial angiotensin II receptor expression and ischemia-reperfusion injury | Q56902847 | ||
Arachidonic Acid Metabolites Mediate Angiotensin II-Induced NADH/NADPH Oxidase Activity and Hypertrophy in Vascular Smooth Muscle Cells | Q63365779 | ||
[Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells | Q67655690 | ||
Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells | Q35059397 | ||
Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system | Q35127232 | ||
Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control | Q35239288 | ||
Oxidized CaMKII causes cardiac sinus node dysfunction in mice. | Q35572691 | ||
Left ventricular hypertrophy in hypertension: its arrhythmogenic potential | Q35583519 | ||
Metabolic stress, reactive oxygen species, and arrhythmia. | Q35690954 | ||
Vascular NADPH oxidases: molecular mechanisms of activation. | Q35994483 | ||
Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes | Q36368961 | ||
Regulation of swelling-activated Cl(-) current by angiotensin II signalling and NADPH oxidase in rabbit ventricle | Q36516270 | ||
Mitochondrial ROS-induced ROS release: an update and review | Q36531183 | ||
A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria | Q36598819 | ||
Angiotensin II and oxidative stress | Q36843758 | ||
Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation | Q36909938 | ||
Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms | Q37078723 | ||
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy | Q37091220 | ||
Angiotensin II effects on ischemic focal ventricular tachycardia are predominantly mediated through myocardial AT(2) receptor | Q37174932 | ||
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure | Q37202675 | ||
Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. | Q37208100 | ||
NADPH oxidases and angiotensin II receptor signaling | Q37342232 | ||
Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation | Q37354665 | ||
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors | Q37365932 | ||
The angiotensin II type 2 receptor in cardiovascular disease | Q37622575 | ||
Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species | Q37685389 | ||
Oxidative stress and hypertension: current concepts | Q37738029 | ||
CaMKII in myocardial hypertrophy and heart failure | Q37833230 | ||
CaMKII in the cardiovascular system: sensing redox states. | Q37899670 | ||
Atrial fibrillation pathophysiology: implications for management. | Q37956126 | ||
Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors | Q39421271 | ||
Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation | Q40571173 | ||
Angiotensin II receptors and angiotensin II receptor antagonists. | Q40846126 | ||
Levels of angiotensin and molecular biology of the tissue renin angiotensin systems | Q40872210 | ||
Angiotensin II-induced association of phospholipase Cgamma1 with the G-protein-coupled AT1 receptor | Q41049990 | ||
Counterregulatory actions of angiotensin-(1-7). | Q41607078 | ||
Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling. | Q41873666 | ||
AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions | Q42014112 | ||
Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis | Q42150753 | ||
Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling | Q42561090 | ||
Angiotensin II and myocyte growth: role of fibroblasts | Q42662003 | ||
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II. | Q42776854 | ||
Disruption of Rac1 signaling reduces ischemia-reperfusion injury in the diabetic heart by inhibiting calpain | Q42872773 | ||
Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species | Q43256386 | ||
P433 | issue | 4 | |
P304 | page(s) | 34-44 | |
P577 | publication date | 2012-08-01 | |
P1433 | published in | World journal of hypertension | Q27725349 |
P1476 | title | Oxidative stress-mediated effects of angiotensin II in the cardiovascular system | |
P478 | volume | 2 |
Q91640579 | An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome |
Q41116394 | Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expression |
Q33812887 | Essential hypertension and oxidative stress: New insights |
Q38272560 | Hypertension and insulin resistance: implications of mitochondrial dysfunction |
Q38703649 | S1P receptor 1-Mediated Anti-Renin-Angiotensin System Cardioprotection: Pivotal Role of Mast Cell Aldehyde Dehydrogenase Type 2. |
Q64084319 | Telomerase Deficiency Predisposes to Heart Failure and Ischemia-Reperfusion Injury |
Q55035093 | The Renin-Angiotensin-Aldosterone System as a Therapeutic Target in Late Injury Caused by Ischemia-Reperfusion. |
Q58705720 | The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy |
Q35837205 | Thioredoxin Activates MKK4-NFκB Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells. |
Search more.